These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 263296)

  • 1. Changes in NSILA-S in response to somatotropin administration and hypophysectomy.
    Franklin RC; Rennie GC; Burger HG; Cameron DP
    J Clin Endocrinol Metab; 1978 Jul; 47(1):91-6. PubMed ID: 263296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of response of nonsuppressible insulin-like activity to short term administration of human growth hormone in thalassemia major.
    Werther GA; Matthews RN; Burger HG; Herington AC
    J Clin Endocrinol Metab; 1981 Oct; 53(4):806-9. PubMed ID: 7026588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A bioassay for NSILA-S in individual serum samples and its relationship to somatotropin.
    Franklin RC; Rennie GC; Burger HG; Cameron DP
    J Clin Endocrinol Metab; 1976 Nov; 43(5):1164-9. PubMed ID: 993319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of a specific serum carrier protein of nonsuppressible insulin-like activity in vivo.
    Kaufmann U; Zapf J; Torretti B; Froesch ER
    J Clin Endocrinol Metab; 1977 Jan; 44(1):160-6. PubMed ID: 833254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsuppressible insulin-like activity (NSILA). II. Regulation of serum concentrations by growth hormone and insulin.
    Heinrich UE; Schalch DS; Koch JG; Johnson CJ
    J Clin Endocrinol Metab; 1978 Apr; 46(4):672-8. PubMed ID: 573281
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the possible mechanism for deficiency of nonsuppressible insulin-like activity in thalassemia major.
    Herington AC; Werther GA; Matthews RN; Burger HG
    J Clin Endocrinol Metab; 1981 Mar; 52(3):393-8. PubMed ID: 6257746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating NSILA-s in man: Preliminary studies of stimuli in vivo and of binding to plasma components.
    Megyesi K; Kahn CR; Roth J; Gorden P
    J Clin Endocrinol Metab; 1975 Sep; 41(3):475-84. PubMed ID: 169287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine influences on serum acid-ethanol soluble non-suppressible in insulin-like activity (NSILA-S).
    Franklin RC; Rennie GC; Burger HG; Cameron DP
    Clin Endocrinol (Oxf); 1980 Feb; 12(2):127-36. PubMed ID: 6772355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsuppressible insulin-like activity (NSILA). I. Development of a new sensitive competitive protein-binding assay for determination of serum levels.
    Schalch DS; Heinrich UE; Koch JG; Johnson CJ; Schlueter RJ
    J Clin Endocrinol Metab; 1978 Apr; 46(4):664-71. PubMed ID: 755052
    [No Abstract]   [Full Text] [Related]  

  • 10. Receptor binding and effects of insulin and NSILA-S on glucose transport and metabolism in adipocytes from hypophysectomized rats.
    Schoenle E; Zapf J; Froesch ER
    Diabetologia; 1979 Jan; 16(1):41-6. PubMed ID: 761737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of hypophysectomy on NSILA concentrations in the dog: evidence for partially pituitary-independent regulation.
    Eigenmann JE; Becker M; Kammermann B; Zapf J; Leemann W; Froesch ER
    Acta Endocrinol (Copenh); 1977 Nov; 86(3):498-503. PubMed ID: 579020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NSILA and foetal growth.
    Heinrich UE; Schalch DS; Jawadi MH; Johnson CJ
    Acta Endocrinol (Copenh); 1979 Mar; 90(3):534-43. PubMed ID: 425788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective analysis of 151 cases of patients with acromegaly operated by one neurosurgeon: a follow-up of more than 23 years.
    Abbassioun K; Amirjamshidi M; Mehrazin A; Khalatbary I; Keynama M; Bokai H; Abdollahi M
    Surg Neurol; 2006 Jul; 66(1):26-31; discussion 31. PubMed ID: 16793431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of the acid-ethanol soluble component of non-suppressible insulin-like activity in untreated and treated streptozotocin-diabetic rats.
    Franklin RC; Rennie GC; Cameron DP
    J Endocrinol; 1979 Jun; 81(3):331-7. PubMed ID: 469463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the action of nonsuppressible insulin-like activity on isolated rat fat cells by binding to its carrier protein.
    Zapf J; Schoenle E; Jagars G; Sand I; Grunwald J; Froesch ER
    J Clin Invest; 1979 May; 63(5):1077-84. PubMed ID: 447829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of serum nonsuppressible insulin-like activity (NSILA) in compensatory renal growth.
    Poffenbarger PL; Prince MJ
    Growth; 1976 Mar; 40(1):83-97. PubMed ID: 177337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acid-ethanol-extractable nonsuppressible insulin-like activity (NSILA-S) during pregnancy and the puererium, and in cord serum at term.
    Franklin RC; Pepperell RJ; Rennie GC; Cameron DP
    J Clin Endocrinol Metab; 1979 Apr; 48(4):695-9. PubMed ID: 429513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain growth-promoting activity in human serum: relationship to growth hormone and somatomedin.
    Sara VR; Stuart MC; Rutherford R; Moore S; Lazarus L
    J Clin Endocrinol Metab; 1978 Nov; 47(5):1129-31. PubMed ID: 263343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone maintains its own receptors in rat adipocytes.
    Grichting G; Goodman HM
    Endocrinology; 1986 Aug; 119(2):847-54. PubMed ID: 3015559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation between carrier-bound forms of non-suppressible insulin-like activity (NSILA) in serum.
    Cornell HJ; Bistrin M; Herington AC
    Int J Biochem; 1985; 17(9):1003-8. PubMed ID: 4065403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.